Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ashish K Asthana is active.

Publication


Featured researches published by Ashish K Asthana.


Korean Journal of Parasitology | 2009

External Ophthalmomyiasis Caused by Oestrus ovis: A Rare Case Report from India

Anita Pandey; Molly Madan; Ashish K Asthana; Anupam Das; Sandeep Kumar; K Jain

Myiasis of different organs has been reported off and on from various regions in the world. We report a human case of external ophthalmomyiasis caused by the larvae of a sheep nasal botfly, Oestrus ovis, for the first time from Meerut city in Western Uttar Pradesh, India. A 25-year-old farmer presented with severe symptoms of conjunctivitis. The larvae, 3 in number, were observed in the bulbar conjunctiva, and following removal the symptoms of eye inflammation improved within a few hours.


Indian Journal of Pathology & Microbiology | 2010

Physician accessories: doctor, what you carry is every patient's worry?

Anita Pandey; Ashish K Asthana; Rupesh Tiwari; Lalit Kumar; Anupam Das; Molly Madan

BACKGROUND Nosocomial infections are on the rise worldwide and many a times they are carried by the health care personnel. Accessories used by physicians and healthcare personnel can be a potential source of nosocomial infection. MATERIALS AND METHODS We designed a survey with the aim to investigate the prevalence of microbial flora of accessories such as pens, stethoscopes, cell phones and white coat used by the physicians working in a tertiary care hospital. OBSERVATIONS It was observed that 66% of the pens, 55% of the stethoscopes, 47.61% of the cell phones and 28.46% of the white coats used by the doctors were colonized with various microorganisms. Staphylococcus spp. was the predominant isolate followed by Escherichia coli. Methicillin resistance in Staphylococcus aureus was also found, which was a matter of concern. CONCLUSIONS Awareness of appropriate hand hygiene is important in order to prevent potential transmission to patients.


International Journal of Infectious Diseases | 2011

Maxillary osteomyelitis by mucormycosis: report of four cases.

Anita Pandey; Vishal Bansal; Ashish K Asthana; Vikas Trivedi; Molly Madan; Anupam Das

Mucormycosis is a fungal infection commonly affecting structures in the head and neck, such as the air sinuses, orbits, and the brain. Common predisposing factors include diabetes mellitus and immunosuppression. We describe our clinical experience with four cases of mucormycosis of the maxillary antrum associated with uncontrolled diabetes mellitus managed at our centre. Early diagnosis and prompt treatment can significantly reduce the mortality and morbidity of this lethal fungal infection.


Asian Pacific Journal of Tropical Disease | 2014

Isolation of Shigella species and their resistance patterns to a panel of fifteen antibiotics in mid and far western region of Nepal

Salman Khan; Priti Singh; Mukhtar Ansari; Ashish K Asthana

Objective To determine the antimicrobial resistance patterns of Shigella species to the most commonly used antibiotics in mid and far western part of Nepal.


Indian Journal of Medical Microbiology | 2010

Accidental intestinal myiasis caused by genus Sarcophaga

Anupam Das; Anita Pandey; Molly Madan; Ashish K Asthana; A. Gautam

Myiasis of different organs has been reported off and on from various regions in the world. We report a human case of intestinal myiasis caused by larvae of Sarcophaga. A 25 - year - old male presented with symptom of passage of live worms in stool. Following diagnosis and treatment the patient improved completely with cessation of maggots in stool.


Indian Journal of Pathology & Microbiology | 2015

Evaluation of phenotypic tests for detection of Klebsiella pneumoniae carbapenemase and metallo-beta-lactamase in clinical isolates of Escherichia coli and Klebsiella species

Kalpana Chauhan; Anita Pandey; Ashish K Asthana; Molly Madan

CONTEXT Carbapenemase production is an important mechanism responsible for carbapenem resistance. AIMS Phenotypic detection and differentiation of types of carbapenemase in carbapenem resistant Enterobacteriaceae is important for proper infection control and appropriate patient management. SETTINGS AND DESIGN We planned a study to determine the occurrence of Class A Klebsiella pneumoniae carbapenemase (KPC type) and Class B Metallo-β-lactamase (MBL type) carbapenemase in hospital and community. MATERIALS AND METHODS Clinical isolates of Escherichia coli and Klebsiella species and simultaneously evaluate different phenotypic methods for detection of carbapenemases. RESULTS It was observed that 20.72% clinical isolates of E. coli and Klebsiella spp. were resistant to carbapenem on screening of which, 14.64% were E. coli and 29.69% were Klebsiella spp. Using phenotypic confirmatory tests the occurrence of carbapenemase production was found to be 87.01% in E. coli and 91.51% in Klebsiella spp. using both modified Hodge test (MHT) and combined disk test (CDT) using imipenem-ethylenediaminetetraacetic acid. CONCLUSIONS Both MBL and KPC type carbapenemases were seen among clinical isolates of E. coli and Klebsiella spp. CDT is simple, rapid and technically less demanding procedure, which can be used in all clinical laboratories. Supplementing MHT with CDT is reliable phenotypic tests to identify the class A and class B carbapenemase producers.


Indian Journal of Pathology & Microbiology | 2013

Evaluation of phenotypic tests for the detection of AmpC beta-lactamase in clinical isolates of Escherichia coli.

Deepika Handa; Anita Pandey; Ashish K Asthana; Ashutosh Rawat; Seemant Handa; Bhaskar Thakuria

BACKGROUND AmpC beta lactamases are cephalosporinases that confer resistance to a wide range of beta lactam drugs thereby causing serious therapeautic problem. As there are no CLSI guidelines for detection of AmpC mediated resistance in Gram negative clinical isolates and it may pose a problem due to misleading results, especially so in phenotypic tests. Although cefoxitin resistance is used as a screening test, it does not reliably indicate AmpC production. MATERIALS AND METHODS We planned a study to determine the occurrence of AmpC beta lactamase in hospital and community, clinical isolates of Escherichia coli and simultaneously evaluate different phenotypic methods for detection of AmpC beta lactamases. RESULTS It was observed that 82.76% isolates were ESBL positive and 59% were cefoxitin screen positive. Using phenotypic confirmatory tests the occurrence of Amp C beta lactamases was found to be 40% and 39% by inhibitor based method using boronic acid (IBM) and modified three dimensional test (M3D) respectively. CONCLUSION Both the test showed concordant result. Co-production was observed in 84.62% isolates Screening of ESBL and Amp C can be done in routine clinical microbiology laboratory using aztreonam and IBM respectively as it is a simple, rapid and technically less demanding procedure which can be used in all clinical laboratories.


Indian Journal of Pathology & Microbiology | 2014

Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.

Soniya Sharma; Molly Madan; Charu Agrawal; Ashish K Asthana

AIM This study was performed for the rapid identification of Mycobacterium tuberculosis complex and its resistance to rifampicin and isoniazid, directly from the sputum samples of pulmonary tuberculosis patients. MATERIALS AND METHODS A commercially available genotype MTBDR plus assay was used for the identification and detection of mutations in Mycobacterial isolates. A total of 100 sputum samples of pulmonary tuberculosis patients were analyzed by using the genotype MTBDR plus assay. The MTBDR plus assay is designed to detect the mutations in the hotspot region of rpoB gene, katG and regulatory region of inhA gene. RESULTS The genotype MTBDR plus assay detected 22% multidrug resistant (MDR), 2% rifampicin (RMP) monoresistant and 1% isoniazid (INH) monoresistant isolates. In 22 MDR isolates, the codons most frequently involved in RMP-associated mutations were codon 531 (54.55%), 516 (31.82%) and 526 (13.63%), and 90.90% of MDR isolates showed KatG S315T mutations and 9.1% showed inhA C-15T mutations associated with INH resistance. CONCLUSION The new genotype MTBDR plus assay represents a rapid, reliable tool for the detection of MDR-TB, wherein results are obtained in 5 h allowing early and appropriate treatment, which is essential to cut the transmission path and reduce the spread of MDR-TB. The genotype MTBDR plus assay can readily be included in a routine laboratory work for the early diagnosis and control of MDR-TB.


Indian Journal of Medical Microbiology | 2014

Mixed pulmonary infection in an immunocompromised patient: A rare case report

S Qureshi; Anita Pandey; Tr Sirohi; Sr Verma; V Sardana; C Agrawal; Ashish K Asthana; Molly Madan

Patients who are immunocompromised are predisposed to a variety of common and uncommon pulmonary infections. We report a case of mixed pulmonary infection by drug resistant tuberculosis with a nocardiosis in a 49-year-old man who was a known case of chronic obstructive pulmonary disease, on prolonged corticosteroid use with diabetes mellitus. Chronic use of corticosteroids is a predisposing factor for opportunistic infections, such as nocardiosis or tuberculosis. Since such a mixed infection is rare, maybe a combined approach to therapy early in the course of disease would be effective in such cases.


Indian Journal of Pathology & Microbiology | 2014

Extended spectrum beta lactamase producing Proteus penneri: A rare missed pathogen?

Anita Pandey; Himani Verma; Ashish K Asthana; Molly Madan

Indole negative Proteus species are invariably incorrectly identified as Proteus mirabilis, often missing out isolates of Proteus penneri. We report a case of extended spectrum beta lactamase producing and multidrug-resistant P. penneri isolated from pus from pressure sore of a patient of road traffic accident. Correct and rapid isolation and identification of such resistant pathogen are important as they are significant nosocomial threat.

Collaboration


Dive into the Ashish K Asthana's collaboration.

Top Co-Authors

Avatar

Molly Madan

Swami Vivekanand Subharti University

View shared research outputs
Top Co-Authors

Avatar

Anita Pandey

Swami Vivekanand Subharti University

View shared research outputs
Top Co-Authors

Avatar

Anupam Das

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Ritu Kansal

Swami Vivekanand Subharti University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charu Agrawal

Swami Vivekanand Subharti University

View shared research outputs
Top Co-Authors

Avatar

Kalpana Chauhan

Swami Vivekanand Subharti University

View shared research outputs
Top Co-Authors

Avatar

C Agrawal

Swami Vivekanand Subharti University

View shared research outputs
Researchain Logo
Decentralizing Knowledge